Staphylococcus aureus biofilm assembly

Staphylococcus aureus biofilm assembly is a complex, multi-stage biological process through which planktonic bacteria transition into a protected, sessile community encased within a self-produced extracellular polymeric substance (EPS) matrix. This assembly involves initial attachment to biotic or abiotic surfaces via specialized proteins known as MSCRAMMs, followed by maturation characterized by the production of Polysaccharide Intercellular Adhesin (PIA) and the accumulation of extracellular DNA (eDNA). These biofilms serve as a major virulence factor by providing a physical barrier that confers up to 1,000-fold higher resistance to antibiotics and protects bacteria from host immune responses, leading to chronic and recalcitrant infections. Therapeutic targeting of this process focuses on disrupting the matrix architecture, inhibiting the regulatory pathways like the Agr quorum-sensing system that coordinate assembly, or preventing initial bacterial adhesion to medical implants. By specifically targeting the assembly and maintenance of the biofilm rather than just bacterial viability, these strategies aim to sensitize persistent bacteria to conventional antimicrobial therapy and the host's innate immune system.

Other names

S. aureus biofilm formationStaphylococcus aureus biofilm developmentStaphylococcal biofilm maturationS. aureus EPS production

Degradation of extracellular DNA (eDNA); Inhibition of Polysaccharide Intercellular Adhesin (PIA/PNAG) synthesis; Interference with the Accessory Gene Regulator (Agr) quorum-sensing system; Disruption of microbial surface components recognizing adhesive matrix molecules (MSCRAMMs); Enzymatic cleavage of matrix proteins.